Decreased serum level of thioredoxin 1 in female patients with pneumonia and its combinational use with haptoglobin for the specific diagnoses of pneumonia and lung cancer

Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000;267:6102–9. http://www.dx.doi.org/10.1046/j.1432-1327.2000.01701.x PMID:11012661

Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351–69. http://www.dx.doi.org/10.1146/annurev.immunol.15.1.351 PMID:9143692

Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992;267:24161–4. PMID:1332947

Holmgren A. Thioredoxin. Annu Rev Biochem 1985;54:237–71. http://www.dx.doi.org/10.1146/annurev.bi.54.070185.001321 PMID:3896121

Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596–606. http://www.dx.doi.org/10.1093/emboj/17.9.2596 PMID:9564042

Rosen A, Lundman P, Carlsson M, Bhavani K, Srinivasa BR, Kjellström G et al. A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int Immunol 1995;7:625–33. http://www.dx.doi.org/10.1093/intimm/7.4.625 PMID:7547690

Schenk H, Vogt M, Dröge W, Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J Immunol 1996;156:765–71. PMID:8543831

Cha MK, Suh KH, Kim IH. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 2009;28:93. http://www.dx.doi.org/10.1186/1756-9966-28-93 PMID:19566940

Wassell J. Haptoglobin: function and polymorphism. Clin Lab 2000;46:547–52. PMID:11109501

Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589–600. PMID:8855140</jrn>

Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004;121 Suppl:S97–104. PMID:15298155

Xu J, Li T, Wu H, Xu T. Role of thioredoxin in lung disease. Pulm Pharmacol Ther 2012;25:154–62. http://www.dx.doi.org/10.1016/j.pupt.2012.01.002 PMID:22293327

Beckman G, Eklund A, Fröhlander N, Stjernberg N. Haptoglobin groups and lung cancer. Hum Hered 1986;36:258–60. http://www.dx.doi.org/10.1159/000153638 PMID:3759102

Awadallah SM, Atoum MF. Haptoglobin polymorphism in breast cancer patients form Jordan. Clin Chim Acta 2004;341:17–21. http://www.dx.doi.org/10.1016/j.cccn.2003.10.032 PMID:14967153

Zhao C, Annamalai L, Guo C, Kothandaraman N, Koh SC, Zhang H et al. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia 2007;9:1–7. http://www.dx.doi.org/10.1593/neo.06619 PMID:17325738

Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection 2004;32:234–8. http://www.dx.doi.org/10.1007/s15010-004-3107-z PMID:15293080

Christ-Crain M, Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:556–73. http://www.dx.doi.org/10.1183/09031936.00166106 PMID:17766633

Classes of heart failure. 2015 [cited 2015 Mar 31]; Available from: http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure_UCM_306328_Article.jsp

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24. http://www.dx.doi.org/10.1002/art.1780310302 PMID:3358796